Download 2. Professor Amin Rostami (PharmD, PhD, FCP

MOHAMMADREZA SATTARI
Home Address: Unit 1805, 7 Lorraine Dr., Toronto, Ontario, M2N 7H2
Tel: (416) 633-3205, Mobile: (647) 286-3635, E-mail: [email protected]
Work Address: Clinical Pharmacology & Toxicology, SickKids Hospital, 555 University Avenue,
Toronto, Ontario, M5G 1X8, E-mail: [email protected]
http://scholar.google.com/citations?user=gNrgO3AAAAAJ&hl=en
https://www.researchgate.net/profile/Mohammadreza_Ghandforoush-Sattari/
http://ir.linkedin.com/pub/mohammadreza-sattari/33/605/420
LANGUAGES
Language
English
Farsi
Turkish
Arabic
Writing
Fluent
Fluent
Intermediate
Basic
Speaking
Intermediate
Fluent
Fluent
Basic
EDUCATION
 Certificate of OSLT from College-Boreal (Toronto, Canada) in Health Sciences,
2015
 Certificate of LINC from College-Boreal (Toronto, Canada), 2015
 PhD in Clinical Pharmacology and Toxicology from School of Medicine, Cardiff
University, Cardiff, UK
2005
 Certificate in Biomedical Research Methods, from School of Medicine, Cardiff
University, Cardiff, UK
2001
 Diploma in Medical Toxicology, from School of Medicine, Cardiff University,
Cardiff, UK
2001
 PharmD in Pharmacy, from Faculty of Pharmacy, Tabriz University of Medical
Sciences, Tabriz, Iran
1992
RESEARCH INTERESTS/RESEARCH TECHNIQUES
 Over 23 years of experience in research on toxicity of drugs, working in clinical
labs, lab management, and analysis of drugs and their metabolites, alcohols, and
biochemical biomarkers in biological samples with strong ability in working with
some lab devices e.g. HPLC, GC, ELISA, Spectrophotometer, …
 15 years excellent experience in team working in clinical trials, lab working
 Analysis of data with excellent ability in working with computer: Windows, MS
Word, MS Excel, SPSS, Prism, EndNote, WinNonlin, and internet
 Excellent research record with more than 40 publications in pharmacology, toxicology,
medical and environmental journals
 A large number of presentations at international forums
 Good collaboration and teamwork with forensic and legal offices, veterinary centers,
poisoning wards of hospitals in crime investigations, diagnosis of poisonings and overdose
in human and animals (e.g. determination of alcohols, opiates, and other medicines in
biological samples)
 Review of few hundred manuscripts from many scientific journals
1
PUBLICATIONS
1. Mashayekhi SO, Ghandforoush-sattari MR, Hain RWD, Nixon LS (2007),
Morphine-6-glucuronide assay using a competitive ELISA assay,
Pharmaceutical Sciences, Spring: 51-60
2. Ghandforoush-Sattari M and Mashayekhi S (2007). Plasma taurine
concentration as a biomarker of liver damage in paracetamol poisoning.
Toxicology Letters, Volume 172, Supplement 1, Page S132
3. Ghandforoush-Sattari M, Mashayekhi SO, Thompson JP, and Routledge PA
(2007). Admissions to the Cardiff Poisons Unit involving paracetamol poisoning
(1989–2002). Toxicology Letters, Volume 172, Supplement 1, Page S229
4. Ghandforoush-Sattari M, Mashayekhi SO (2008), Evaluation of taurine as a
biomarker of liver damage in paracetamol poisoning, European Journal of
Pharmacology, 581: 171-176
5. Ghandforoush-Sattari M, Mashayekhi SO (2008). A rapid determination of
histamine and 3-methylhistamine in human plasma by high performance liquid
chromatography. Toxicological & Environmental Chemistry; 90 (4): 787 - 793
6. Ghandforoush-Sattari M, Mashayekhi SO (2008). Admissions to the Cardiff
Poisons Unit involving paracetamol poisoning (1989-2002), Toxicological &
Environmental Chemistry; 90 (4): 663 - 671
7. Mashayekhi SO, Ghandforoush-Sattari MR, and Hain RDW (2008). Rapid and
sensitive quantitation of morphine using HPLC with electrochemical detection.
Journal of Clinical Pharmacy and Therapeutics; 33: 1–9
8. Mashayekhi SO, Ghandforoush-Sattari M, Routledge PA, Hain RDW (2009).
Pharmacokinetic and Pharmacodynamic Study of Morphine and Morphine 6Glucuronide after Oral and Intravenous Administration of Morphine in
Children with Cancer. Biopharmaceutics & Drug Disposition; 30(3): 99-106
9. Mashayekhi S, Ghandforoush-Sattari M, Rahimipour A (2010). Serum lipase
concentration in end stage renal patients receiving hemodialysis. Saudi Journal
of Kidney Diseases and Transplantation; 21(6): 1143-1144
10. Mashayekhi S, Dilmaghanizadeh M, Fardiazar Z, Bamdad-Moghadam R,
Ghandforoush-Sattari M. Study of awareness among pregnant women of the
effects of drugs on the fetus and mother in Iran. Health Policy (2008),
doi:10.1016/j.healthpol.2008.11.011
11. Ghandforoush-Sattari M; Mashayekhi S (2008). Pharmacokinetics of oral
taurine in healthy volunteers. Pharmacy World & Science; 30(5): 724
2
12. Ghandforoush-Sattari M, Mashayekhi SO, Nemati M, Routledge PA (2009). A
Rapid Determination of Taurine in Human Plasma by LC. Chromatoghraphia;
69 (11-12):1427-1430
13. Ghandforoush-Sattari M, Mashayekhi SO, Nemati M, Seydi A, Azadi H (2010).
Changes in plasma taurine concentration during a period of heroin
detoxification. Toxicological & Environmental Chemistry; 92(8): 1505 - 1512
14. Ghandforoush-Sattari M, Mashayekhi SO, Krishna CV, Thompson JP, Routledge
PA (2010). Pharmacokinetics of oral taurine in healthy volunteers. Journal of
Amino Acids; Article ID 346237:1-5
15. Mashayekhi S.O., Ghandforoush-Sattari M., Buss D.C., Routledge P.A., Hain R.DW
(2010). Impact of anti-cancer drugs and other determinants on serum protein
binding of morphine 6-glucuronide. DARU; 18(2): 107-113
16. Ghandforoush-Sattari M, Zakeri-Milani P, Mashayekhi S, Valizadeh H (2011).
Determination of glyceryl trinitrate and its two main metabolites in human
plasma using a new sensitive gas chromatography method. Arzneimittel
Forschung (Drug Research); 2011;61(3):141-7.
17. Ghandforoush-Sattari M, Mashayekhi SO, Nemati M, Ayromlou H (2011).
Changes in plasma concentration of taurine in stroke. Neurosci Lett.
8;496(3):172-5.
18. Mashayekhi SO, Sattari M, Routledge PA (2010). Evidence of active transport
involvement in morphine transport via MDCKII and MDCK-PGP cell lines.
Res Pharm Sci; 5(2):99-106.
19. Mashayekhi SO, Ghandforoush-Sattari M, Rahimipour A (2010). Serum lipase
concentration in chronic hemodialysis patients. Saudi J Kidney Dis
Transpl;21(6):1143-4.
20. Mashayekhi SO, Dilmaghanizadeh M, Fardiazar Z, Bamdad-Moghadam R,
Ghandforoush-Sattari M (2011). Beliefs and practices of Iranian pregnant
mothers regarding vitamins and minerals. EMHJ ; 17 (3):203-207
3
21. Mashayekhi SO, Ghandforoush-Sattari M, Bagdadchi ME, Khayri M (2011).
Patients’ report of statins use and side-effects in a sample of hospitalized
cardiac patients in the Islamic Republic of Iran. EMHJ; 17 (5)
22. Mashayekhi SO, Dilmaghanizadeh M, Sattari M (2011). A survey on the
consumption, knowledge and attitude of pregnant women toward the effects of
folic acid on pregnancy outcome in Tabriz. Iranian Journal of Child Neurology;
5(1):33-40
23. Islambulchilar M, Sattari M, Sardashti M, Lotfipour F (2011). Effect of Taurine on
the antimicrobial efficiency of Gentamicin. Advanced Pharmaceutical Bulletin;
1(2): 69-74
24. Sattari M, Routledge PA, Mashayekhi SO (2011). The influence of active
transport systems on morphine -6-glucuronide transport in MDCKII and
MDCK-PGP cells. DARU Vol. 19, No. 6
25. Sattari M, Mashayekhi SO (2012). Acetaminophen overdose, biomarkers, and
management. In: Javaherian A, Latifipour P (Eds); Acetaminophen, Properties,
Clinical Uses, and Adverse Effects (Book), Nova Sciences Publishers Inc, Ch. 5: pp
106-148
26. Sattari M, Islambulchilar M, Toluyi M, Mashayekhi SO (2012). Sociodemographic characteristics of the addicted inmates of Qom and Tabriz prisons
in Iran. Advanced Pharmaceutical Bulletin (APB), 2(1), 61-69
27. Sattari M, Dilmaghanizadeh M, Hamishehkar H, Mashayekhi SO (2012). Selfreported Use and Attitudes Regarding Herbal Medicine Safety During
Pregnancy in Iran. Jundishapur J Nat Pharm Prod.7(2), 9-10
28. Mashayekhi S, Sattari M, Maleki-Dizaji N, Asadi M, Islamboulchilar M,
Parvizpour A, Alizadeh M, Esfahani A, Ardalan M, Soumi MH, Farhoodi M,
Ranjbar F, Varshochi M, Hamishehkar H (2012). Pharmacy Students' SelfIdentified Interests in a Hospital Pharmacy Internship Course in Iran. Res Dev
Med Educ, 1(2), 49-53
29. Sattari M, Mashayekhi SO, Mashayekhi S (2012). Islam and Addiction.
Pharmaceutical Sciences. 18(3), 1-8
4
30. Sattari M, Sheykhi D, Nikanfar A, Pourfeizi AH, Nazari M, Dolatkhah R,
Mashayekh SO (2012). The Financial and Social Impact of Thalassemia and Its
Treatment in Iran. Pharmaceutical Sciences. 18(3), 171-176
31. Sattari M, Sheykhi D, Nikanfar A, Pourfeizi AH, Nazari M, Dolatkhah R,
Hamishehkar H, Mashayekh SO (2013). The Adverse Effects of Thalassemia
Treatments Including Blood Transfusion and Main Pharmacological Therapies.
Pharmaceutical Sciences. 18(4), 199-204
32. Sattari M, Mokhtari Z, Jabari H, Mashayekhi SO (2013). Knowledge, attitude and
practice of pharmacists and health-care workers regarding oral contraceptives
correct usage, side-effects and contraindications. EMHJ. 19(6), 554-561
33. Sattari M, Baghdadchi ME, Kheyri M, Khakzadi H, Mashayekhi SO (2013). Study
of Patient Pain Management after Heart Surgery. Advanced Pharmaceutical
Bulletin (APB), 3(3), 373-377
34. Jabbari H, Bakhshian F, Asgari M, Sattari M, Naghavi-Behzad M, Mashayekhi SO
(2013). Antenatal Micronutrient Supplementation Relationship with Children's Weight and Height from Birth up to the Age of 18 Months. Iranian J Publ
Health, 42 (6), 626-634
35. Taziki S, Sattari M, Eghbal MA (2013). Evaluation of amitriptyline-induced
toxicity in freshly isolated rat hepatocytes and the protective role of taurine.
Life Science Journal, 10(8s), 314-320
36. Taziki S, Sattari M, Eghbal MA (2013). Mechanisms of Trazodone‐Induced
Cytotoxicity and the Protective Effects of Melatonin and/or Taurine toward
Freshly Isolated Rat Hepatocytes. Journal of biochemical and molecular
toxicology, 27:457-462
37. Eghbal MA, Taziki S, Sattari M (2013). Protective Role of Melatonin and
Taurine Against Carbamazepine-induced Toxicity in Freshly Isolated Rat
Hepatocytes. International Journal of Morphology, 31(3), 1081-1089
38. Sattari M, Seyedi S, Jabari H, Habibi-Asl B, Zakaria Pezeshki M, Bakhshian F,
Mashayekhi SO (2013). Comparison of Knowledge of Oral Contraceptive Pills
User Women, Who Received their Medication from Pharmacies or Health Care
Centers. Pharmaceutical Sciences, 19(3), 91-95
39. Eghbal MA, Taziki S, Sattari M (2014). Mechanisms of Phenytoin‐Induced
Toxicity in Freshly Isolated Rat Hepatocytes and the Protective Effects of
Taurine and/or Melatonin. Journal of biochemical and molecular toxicology,
28(3), 111-118
40. Islambulchilar M, Asvadi I, Sanaat Z, Esfahani A, Sattari M (2015). Taurine
attenuates chemotherapy‑induced nausea and vomiting in acute lymphoblastic
leukemia. Amino Acids, 47(1), 101–109
5
41. Islambulchilar M, Asvadi I, Sanaat Z, Esfahani A, Sattari M (2015). Effect of
Taurine on Febrile Episodes in Acute Lymphoblastic Leukemia. Advance
Pharmaceutical Bulletin, 5(1): 103-108
42. Salek Maghsoudi A, Sattari M, Ostadi A, Mazloumi Z, Shokrzadeh M (2014).
Evaluation of N-Acetyl Cysteine performance in acetaminophen poisoning
using certain liver and renal factors in plasma. J Kermanshah Univ Med Sci.,
18(7): 388-397 (Persian)
43. Eivazi‑Ziaei J, Asvadi I, Esfahani A, Vaez J, Pourzand A, Shabanloei A, Sattari
MR (2014). Chemotherapy‑induced amenorrhea in patients suffering from
breast cancer in the Northwest of Iran. South Asian Journal of Cancer, 3(4):
233-234
43. Sattari M (2014). How can we live with plastic poisoning? Health Message, Tabriz
University of Medical Sciences, 9: 64-69 (Persian)
44. Sattari M, Mashayekhi S (2015). Obesity and Taurine. Advances in Obesity,
Weight Management & Control, 2(4): 00022
45. Islambulchilar M, Asvadi I, Sanaat Z, Esfahani A, Sattari M (2015). Effect of
taurine on attenuating chemotherapy-induced adverse effects in acute
lymphoblastic leukemia. Journal of Cancer Research and Therapeutics, 11(2): 426432
PRESENTATIONS
1. Ghandforoush-Sattari M (2000); An improved measurement of N-acetylcysteine
in human plasma by high performance liquid chromatography. First Iranian
Medical Sciences Postgraduate Students Conference, August 20-22, 2000, TehranIran
2. Ghandforoush-Sattari M (2002); A modified method for the determination of
taurine in human plasma by high performance liquid chromatography. 9th
Iranian Student Seminar in Europe (Birmingham)
3. Ghandforoush-Sattari M (2002); Study of taurine as a biomarker of paracetamol
poisoning. 17th Annual Postgraduate Research Day, UWCM.
4. Ghandforoush-Sattari M, Thompson JP, Krishna CV, Routledge PA (2006); Effects
of Pre-treatment with Naproxen on the Tolerability of N-acetylcysteine (NAC)
in Healthy Volunteers, 10th Iranian Pharmaceutical Sciences Congress, August 2124, 2006, Tehran, Iran
5. Ghandforoush-Sattari M, Mashayekhi S (2006); Toxicology of Ecstasy, National
Congress of Ecstasy, December 21, 2006, Astara, Iran
6
6. Ghandforoush-Sattari M, Thompson JP, Krishna CV, Routledge PA (2006); Effects
of Pre-treatment with Naproxen on the Tolerability of N-acetylcysteine (NAC)
in Healthy Volunteers, 6th International Congress of Turkish Society of
Toxicology, November 2-5, 2006, Antalya, Turkey
7. Ghandforoush-Sattari MR, Thompson JP, Mashayekhi SO, Routledge PA,
Admissions to the Cardiff Poisons Unit Involving Paracetamol Poisoning (19892002), 9th Iranian congress of Toxicology, May 15-17, 2007, Shiraz, Iran
8. Ghandforoush-Sattari M, Thompson JP, Krishna CV, Routledge PA (2006); Effects
of Pre-treatment with Naproxen on the Tolerability of N-acetylcysteine (NAC)
in Healthy Volunteers, XI International Congress of Toxicology, July 15-19, 2007,
Montreal, Canada
9. Ghandforoush-Sattari M, Krishna CV, Mashayekhi S (2007); Study of
pharmacokinetics of oral taurine in healthy volunteers, Congruence of
Pharmaceutical Sciences, Practice and Research, 25-28.Oct.2007, ManilaPhilippines
10. Mashayekhi S, Ghandforoush-Sattari M, Hain RD, Gumbleton M. Etfects of
Various Transporters in Morphine and Morphine-5-Glucuronide Transport.
Asian Association of Schools of Pharmacy, 3rd Conference, Oct. 25-28, 2007,
Manila-Philippines.
11. Ghandforoush-Sattari MR, Valizadeh H, Zakeri-Milani P, Mashayekhi SO.
Bioequivalence Comparison of Two Brands of Oral Sustained-Release
Nitroglycerin Tablets. 63th FIP Congress of Pharmacy and Pharmaceutical
Sciences, 29th Aug – 4th Sep. 2008. Basel, Switzerland
12. Ghandforoush-Sattari MR, Mashayekhi SO, Nemati M, Azadi H. Can Taurine Be
a Biomarker of Recovery during Withdrawal of Heroin? 63th FIP Congress of
Pharmacy and Pharmaceutical Sciences, 29th Aug – 4th Sep. 2008. Basel, Switzerland
13. Mashayekhi SO, Ghandforoush-Sattari MR, Hain RDW, Routledge PA. Study
of Morphine Pharmacodynamic in Children with Cancer: Analgesic effects
and side effects. The 7th Scientific Annual Meeting of the Iranian Pain Society,
2007.
14. Mashayekhi SO, Ghandforoush-Sattari MR, Hain RDW, Gumbelton M.
Morphine-6-glucuronide; active transport various transport systems, 3rd Iranain
Conference of Novel Drug Delivery Systems, 21tst – 22nd June 2007, Tehran – Iran
15. Mashayekhi SO, Ghandforoush-Sattari MR, Hain RDW, Gumbelton M.
Morphine; active transport via MDCKII and MDCK-PGP cell lines. 3rd Iranain
Conference of Novel Drug Delivery Systems, 21tst – 22nd June 2007, Tehran – Iran.
16. Mashayekhi S, Ghandforoush-Sattari M, Hain R, Gumbleton M. Are morphine
and morphine-6-glucuronide P-Glycoprotein substrates? Asian Association of
Schools of Pharmacy, 3rd Conference, Oct. 25-28, 2007, Manila-Philippines.
7
17. Mashayekhi SO, Ghandforoush-Sattari MR, Clinical trials of medicines in
children. The 2nd international congress of Medical Ethics in Iran. 16-18 April 2008.
18. Mashayekhi SO, Ghandforoush-Sattari MR, The use of off label medicines in
children. The 2nd international congress of Medical Ethics in Iran. 16-18 April
2008.
19. Mashayekhi SO, Ghandforoush-Sattari MR, Participating in clinical trials. The
2nd international congress of Medical Ethics in Iran. 16-18 April 2008.
20. Mashayekhi SO, Dilmaghanizadeh M, Fardiazar Z, Bamdad-Moghadam R,
Ghandforoush-Sattari MR, Study of awareness among pregnant women of the
effects of vitamins and minerals supplements on the fetus and mother in
Northwest of Iran. 68th FIP World Congress of Pharmacy and Pharmaceutical
Sciences. Basel Switzerland. 29th Aug- 4th Sep 2008.
21. Mashayekhi S., Maleki N., Ghandforoush-Sattari MR., Nayebi A., Parvizpour A.,
Alizadeh M., Azarmi Y., Zakeri P., Establishment Of Hospital Pharmacy
Internship For Pharmacy Students. 10th National Medical Sciences Education
Seminar, 5-7 May, 2009, Shiraz, Iran.
22. Mashayekhi SO., Ghandforoush-Sattari M., Study of awareness among pregnant
women of the effects of herbal medications on the fetus and mother in
Northwest of Iran. Traditional and conplementary medicines. 27-30 Oct. 2008,
Sari, Iran.
23. Ghandforoush-Sattari MR, Mashayekhi SO., Ethics and Pharmaceutical
Industry. 10th Asian Bioethics Conference and Fourth Unesco Asia-Pacific School
of Ethics Roundtable. 26-29 Apr. 2009, Tehran, Iran
24. Ghandforoush-Sattari MR, Mashayekhi SO., Deficiencies and Difficulties in
Performance of the Medical Ethics Declarations. 10th Asian Bioethics Conference
and Fourth Unesco Asia-Pacific School of Ethics Roundtable. 26-29 Apr. 2009,
Tehran, Iran
25. Ghandforoush-Sattari MR, Mashayekhi SO., Ethics, Negligence and Medicines.
10th Asian Bioethics Conference and Fourth Unesco Asia-Pacific School of Ethics
Roundtable. 26-29 Apr. 2009, Tehran, Iran
26. Ghandforoush-Sattari MR, Mashayekhi SO, Nemati M, Seydi S, Azadi H.
Changes in plasma taurine concentration during withdrawal of heroin. 10th
Iranian Congress of Toxicology & Poisoning, 18-20 May 2009. Shahid Beheshti
University of Medical Sciences, Tehran, Iran
27. Ghandforoush-Sattari M, Valizadeh H, Zakeri-Milani P, Mashayekhi S. A
developed method for determination of nitroglycerin’s metabolites in human
plasma. 4th Asian association of schools of pharmacy conference (AASP). 10-13
June 2009. Penang, Malaysia
8
28. Mashayekhi SO, Ghandforoush-Sattari M, Maleki N, Asadi M, Islambulchilar M,
Parvizpour A, Alizadeh A. Learning topics of pharmacy doctorate students
during hospital pharmacy internship. 4th. Asian association of schools of
pharmacy conference (AASP). 10-13 June 2009. Penang, Malaysia
29. Mashayekhi SO, Ghandforoush-Sattari M, Baghdadchi ME, Kheyri M. Statins
use and side effects in a cardiac hospital in Iran. 4th. Asian association of schools
of pharmacy conference (AASP). 10-13 June 2009. Penang, Malaysia
30. Ghandforoush-Sattari M, Valizadeh H, Zakeri-Milani P, Mashayekhi S.
Bioequivalence study of an Iranian brand of oral sustained-release
nitroglycerin compared with a similar imported one . 4th. Asian association of
schools of pharmacy conference (AASP). 10-13 June 2009. Penang, Malaysia
31. Ghandforoush-Sattari M, Mashayekhi S, Mirkazemi R, Sanaat Z, Esfahani A.
Could Taurine be as a biomarker in lung cancer? 12th Iranian Pharmaceutical
Sciences Congress, 2-5 Aug. 2010. Zanjan University of Medical Sciences, Zanjan,
Iran
32. Mashayekhi S, Khoshniat S, Ghandforoush-Sattari M, Nikanfar A, Hosseynpour
Feizi A. Study of adverse effects of anticoagulating factors replacement in
haemophilia patients. 12th Iranian Pharmaceutical Sciences Congress, 2-5 Aug.
2010. Zanjan University of Medical Sciences, Zanjan, Iran
33. Mashayekhi S, Shahidi M, Ghandforoush-Sattari M. Evaluation of pharmacy
students knowledge on various aspects of HIV/AIDS. 12th Iranian Pharmaceutical
Sciences Congress, 2-5 Aug. 2010. Zanjan University of Medical Sciences, Zanjan,
Iran
34. Mashayekhi S, Khoshniat S, Nazari M, Dolatkhah R, Ghandforoush-Sattari M.
Study of adverse effects of medication used in treatment of hemophilia patients.
12th Iranian Pharmaceutical Sciences Congress, 2-5 Aug. 2010. Zanjan University of
Medical Sciences, Zanjan, Iran
35. Ghandforoush-Sattari M, Mashayekhi S. Why drugs should be prohibited in
Islam? 12th Iranian Pharmaceutical Sciences Congress, 2-5 Aug. 2010. Zanjan
University of Medical Sciences, Zanjan, Iran
36. Ghandforoush-Sattari M, Mashayekhi S, Sanaat Z, Esfahani A. Taurine in lung
cancer, MASCC/ISOO 2011 International Symposium on Supportive Care in
Cancer, 23-25 June 2011, Athens, Greece
37. Mashayekhi S, Sheykhi D, Nikanfar A, Hosseinpur-Faizi A, Sattari M. Cost of
thalassemia treatment in Iran, 10th Annual International Conference on Health
Economics, Management & Policy, 27-30 June 2011, Athens, Greece
9
38. Sattari M, Mashayekhi SO, Mortazavi M. Effect of oral contraceptive on plasma
concentration of codeine, 6th European Congress of Pharmacology, 17-20th July.
2012, Granada, Spain
39. Mashayekhi SO, Sattari M, Maleki N, Asvadi-Kermani I. Study of incidence of
amphotericin B side effects and nephrotoxicity risk factors in patients under
chemotherapy, 6th European Congress of Pharmacology, 17-20th July. 2012,
Granada, Spain
40. Sattari M, Mashayekhi SO, Aminian F. Taurine, an early biomarker of druginduced liver necrosis, 8th. Congress of Toxicology in Developing Countries
(8CTDC), 10-13th Sep. 2012, Bangkok, Thailand
41. Sattari M, Mashayekhi SO, Ghahramanifar, Maleki-Dizaji N, Asvadi I, Study of
incidence of amphotericin B side effects and nephrotoxicity risk factors in
patients under chemotherapy, 8th. Congress of Toxicology in Developing
Countries (8CTDC), 10-13th Sep. 2012, Bangkok, Thailand
42. Sattari M, Mashayekhi SO. Naproxen alleviates anaphylactoid reactions to Nacetylcysteine in healthy volunteers. 15th International Congress of Immunology
(ICI), Milan, Italy, 22-27 Aug, 2013.
43. Vaez H, Sattari M, Ayromlou H, Khoshsoroor S, Evaluation of the changes in
plasma concentrations of taurine, glutamate and glycine in stroke patients. 6th
national & first international Iranian stroke congress, Tabriz, Iran, Nov. 2013
RESEARCH EXPERIENCES
1. Study of the correlation between drug addiction and relationships (PharmD thesis,
Tabriz University of Medical Sciences, 1992)
2. Detection of organochlorines by Gas Chromatograpgy (thesis supervision, Tabriz
University of Medical Sciences, 1995)
3. New methods for protection and treatment of addiction opiates (thesis supervision,
Tabriz University of Medical Sciences, 1997)
4. Studies on the optimum management of paracetamol poisoning (PhD thesis, Cardiff
University, 2005)
5. Study of pharmacokinetics of oral taurine, and intravenous N-acetylsycteine (PhD
thesis, Cardiff University, 2000-2004)
6. Comparison of the effects of social parameters on drug addiction between inmates of
Qum and Tabriz prisons (thesis supervision, Tabriz University of Medical Sciences,
2006)
10
7. Study of taurine as a biomarker of stroke (thesis supervision, Tabriz University of
Medical Sciences, 2008)
8. Study of taurine as a biomarker of recovery during withdrawal of opiates (thesis
supervision, Tabriz University of Medical Sciences, 2007)
9. Study of the effects of probencid on the diagnostic laboratory tests of drug addiction
(thesis supervision, 2007)
10. Study of the masking effects of oral contraceptives on the diagnostic laboratory tests
of drug addiction by thin layer chromatography (TLC) (thesis supervision, Tabriz
University of Medical Sciences, 2009)
11. Study of taurine as a biomarker in lung cancer (thesis supervision, Tabriz University
of Medical Sciences, 2010)
12. Investigation of the prevalence of tobacco smoking and its effect on education status
among the students of Tabriz University of Medical Sciences in 2008 (thesis
supervision, Tabriz University of Medical Sciences, 2009)
13. Investigation of the prevalence of drug abuse among the students of Tabriz
University of Medical Sciences in 2008 (thesis supervision, Tabriz University of
Medical Sciences, 2009)
14. Analgesia use and pain assessment in the intensive care unit (ICU) after heart
surgery in Shahid Madani Hospital of Tabriz (Investigation of the prevalence of
tobacco smoking and its effect on education status among the students of Tabriz
University of Medical Sciences in 2008 (thesis supervision, Tabriz University of
Medical Sciences, 2010)
15. Bioequivalence evaluation of sustained-release nitroglycerin tablet produced by
Zahravi compared with an imported brand following administration of a single dose
to healthy volunteers (research project, Tabriz University of Medical Sciences, 2008)
16. Study of contact with benzen as a risk factor of blood malignancies (thesis
supervision, Tabriz University of Medical Sciences, 2010)
17. Study of plasma taurine level in active and passive smokers (thesis supervision,
Tabriz University of Medical Sciences, 2010)
18. Study of the effect of taurine on the antibiotic effect of gentamycine against three
bacterial species (thesis supervision, Tabriz University of Medical Sciences, 2011)
19. Study of the hepatoprotective effect of taurine in patients receiving carbamazepine
(research project, Tabriz University of Medical Sciences, 2011)
20. Evaluation of the changes in plasma concentrations of few free amino acids in
ischemic and non-ischemic stroke patients (thesis supervision, Tabriz University of
Medical Sciences, 2011)
21. Study of changes in plasma taurine concentration in acetaminophen overdose
patients during their hospitalization (thesis supervision, Tabriz University of Medical
Sciences, 2010)
22. Study of the prevalence of drug related liver failure in gastroenterology ward of
Imam Reza hospital of Tabriz (thesis supervision, Tabriz University of Medical
Sciences, 2011)
23. Study of the prevalence of drug related acute and chronic renal failure in nephrology
ward of Imam Reza hospital of Tabriz (thesis supervision, Tabriz University of
Medical Sciences, 2011)
24. The study of adverse reactions of vancomycine and aminoglycosides in the
infectious diseases ward of Imam Reza and sina Hospitals of Tabriz between 1385
and 1390 (thesis supervision, Tabriz University of Medical Sciences, 2011)
11
25. Study of the effects of oral contraceptives on the serum levels of free morphine and
codeine in healthy volunteers (thesis supervision, Tabriz University of Medical
Sciences, 2006)
26. Study of the protective effects of taurine against methotrexate-induced toxicity in the
patients suffering from osteosarcoma (thesis supervision, Tabriz University of
Medical Sciences, 2007)
27. Study of the protective effects of taurine against drug-induced toxicity in the patients
suffering from Acute Lymphoblastic Leukemia (ALL) (thesis supervision, Tabriz
University of Medical Sciences, 2007)
28. Study of the protective effects of taurine against carbamazepine-induced toxicity in
the epileptic patients (thesis supervision, Tabriz University of Medical Sciences,
2007)
29. Changes in plasma taurine concentrations in active and passive smokers (thesis
supervision, Tabriz University of Medical Sciences, 2007)
30. Ethics and pharmaceutical profession in the pharmacies of Tabriz (thesis
supervision, Tabriz University of Medical Sciences, 2008)
31. Study of the protective effects of taurine against drug-induced nephro and ototoxicity in the patients receiving gentamycine (thesis supervision, Tabriz University
of Medical Sciences, 2009)
32. Changes in concentrations of some aminoacids in plasma in liver necrosis (thesis
supervision, Tabriz University of Medical Sciences, 2009)
33. Study of the effects of oral contraceptives on the serum, urine, and hair levels of
morphine in the rat (thesis supervision, Tabriz University of Medical Sciences,
2007)
34. Study of risk factors in breast cancer in women (thesis supervision, Tabriz
University of Medical Sciences, 2013)
TEACHING EXPERIENCES
Toxicology, Forensic Medicine, Clinical trials, Medical terminology, Clinical
Pharmacology, Hospital Pharmacy, Medical Ethics, and Ethics in Clinical Studies for
Pharmacy (PhD, and general), Laboratory Sciences, Toxicology, and veterinary students
from Dec. 1992 to March 2015
ADMINISTRATIVE AND ORGANIZATIONAL SKILLS
 Manager of Pharmaceutical Sciences (Journal of Faculty of Pharmacy, Tabriz
University of Medical Sciences)
2010-2013
 Manager of a Toxicology Lab in Tabriz-Iran
1994-1998
 Manager of the Education Office of Faculty of Pharmacy in Iran
1996
 Member of Tabriz Hematology and Oncology Research Centre in Tabriz-Iran
2007-2014
 Member of Tabriz Infectious and Tropical Diseases Research Centre in Tabriz-Iran
2008-2014
 Member of Tabriz Neurosciences Research Centre in Tabriz-Iran 2010-2014
REFERENCES
12
1. Professor Ali Nokhodchi (PharmD, PhD), Professor of Pharmaceutical Sciences and
Drug Delivery (Biochemistry)
Phone: +44 1273 872811
Email: [email protected]
Address: Arundel Building 407, University of Sussex, Sussex House, Falmer, Brighton, BN1
9RH, UK
2. Professor Amin Rostami (PharmD, PhD, FCP), Professor of Systems Pharmacology
Phone: +44 (0)161 306 0634
Fax: +44 (0)161 275 8349
Email: [email protected]
Address: School of Pharmacy and Pharmaceutical Sciences, Stopford Building,
Oxford Road, Manchester, M13 9PT, UK
3. Professor Philip A. Routledge (MB, MD, MRCP, FRCPE, FBTS), Professor of Clinical
Pharmacology
Phone: +44 (0)29 207 42051 Extension: 42051
Email: [email protected]
Address: Cardiff University School of Medicine, UHW Main Building, Heath Park, Cardiff
CF14 4XN, UK
4. Dr. Faris Farassati (PharmD, PhD), Associate Professor of Molecular Medicine
Phone: +1(0)913 945 6823
Fax: +1(0)913 945 6923
Email: [email protected]
Address: Dept. Internal Medicine, Division of Hematology and Medical Oncology, University
of Kansas Cancer Center, Mail Stop 4037, 1000 Hixon, 3901 Rainbow Blvd., Kansas City, KS
6616, USA
5. Francine Kalogris, OSLT health instructor, College-Borreal, Toronto, Ontario, Canada
Phene: +1 416 520 0418
Email: [email protected]
6. Parvaneh Yazdani, Division of Clinical Pharmacology and Toxicology, SickKids Hospital,
Toronto, Ontario, Canada
Phone: +1 416 813 1500
Email: [email protected]
13